Daniel R Principe

23PUBLICATIONS
18CO-AUTHORS
EcohydrologyMolecular targetsMedical biochemistry - carbohydratesMedical infection agents (incl. prions)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jan 13, 2026
Resistance to the KRASG12D Inhibitor MRTX1133 Is Associated with Increased Sensitivity to BET Inhibition.

Daniel R Principe, Jeffrey H Becker, Anastasia E Metropulos

|Jun 04, 2025
Resistance to the KRASG12D Inhibitor MRTX1133 is Associated with Increased Sensitivity to BET Inhibition.

Daniel R Principe, Jeffrey H Becker, Anastasia E Metropulos

|Aug 13, 2024
Targeting BCL2 with Venetoclax Enhances the Efficacy of the KRASG12D Inhibitor MRTX1133 in Pancreatic Cancer.

Jeffrey H Becker, Anastasia E Metropulos, Christina Spaulding

|Aug 08, 2024
Loss of STK11 Suppresses Lipid Metabolism and Attenuates KRAS-Induced Immunogenicity in Patients with Non-Small Cell Lung Cancer.

Daniel R Principe, Mary M Pasquinelli, Ryan H Nguyen

|Jul 15, 2024
Diabetic ketoacidosis masked by both Euglycemia and a primary metabolic alkalosis.

Matthew F Hillock, Cierra Jarmon, Anastasia E Metropulos

Pageof 4